Concepedia

Publication | Open Access

A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease

206

Citations

26

References

2021

Year

Abstract

In this preliminary trial, treatment with ZED1227 attenuated gluten-induced duodenal mucosal damage in patients with celiac disease. (Funded by Dr. Falk Pharma; CEC-3 EudraCT number, 2017-002241-30.).

References

YearCitations

1997

2K

2012

1.7K

1998

1.2K

2007

743

1998

491

1998

427

2010

396

2013

259

2014

249

2012

234

Page 1